Research And Development
Health
Manufacturing
ACADIA Pharmaceuticals
$29.619876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$29.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.59 (2.03%) Today
$0.00 (0.00%) As of 4:32 PM EDT after-hours
Why Robinhood?
You can buy or sell ACAD and other stocks, options, ETFs, and crypto commission-free!
About ACAD
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. Read More The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Employees
430
Headquarters
San Diego, California
Founded
1993
Market Cap
4.28B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.41M
High Today
$29.85
Low Today
$29.22
Open Price
$29.32
Volume
1.04M
52 Week High
$30.38
52 Week Low
$12.86
Collections
Research And Development
Health
Manufacturing
Pharmaceutical
Technology
Medical
Biotechnology
ACAD News
Price Paid on Robinhood
25% Higher
Right Now
52 Week Low
$12.77
Average Price Paid
$23.69
52 Week High
$28.67
Analyst Ratings
73%
of 11 ratings
Buy
73%
Hold
27%
Sell
0%
ACAD Earnings
-$0.59
-$0.52
-$0.45
-$0.38
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 5, After Hours